More programs, more candles, more light.

Get the Flash Player to see this player.

Loading the player ...

Panel 3: CIRM Disease Team Reports

Introduction by Patricia Olson, California Institute for Regenerative Medicine (CIRM)

November 30, 2011
07 minutes
Patricia Olson


Dr. Olson is responsible for the development, implementation and monitoring of the research funding program of CIRM. She is a former vice president of Chiron Corporation (now Novartis). At Chiron, Dr. Olson led protein therapeutics research, responsible for discovery and preclinical evaluation of candidate therapeutics. Prior to that, she headed portfolio management and strategic planning for the R&D division of Chiron and was a member of the R&D executive committee responsible for oversight and decisions on research, preclinical and clinical development programs. She participated in the development of two marketed products, is an inventor on over 22 issued US patents and an author of over 29 peer-reviewed publications. Dr. Olson received her Ph.D. in biochemistry and biophysics from the University of California at Berkeley and her B.S. in cellular biology (magna cum laude) from the University of Michigan, Ann Arbor.